EFNA1 and gastric adenocarcinoma: In a study of 222 patients with gastric adenocarcinoma that underwent gastrectomy, immunohistochemical analysis of the samples showed that EFNA1 expression suggested a poor disease-specific survival benefit (Miyazaki et al., 2013).